 11-beta-Hydroxysteroid Dehydrogenase Type 1
"11-beta-Hydroxysteroid Dehydrogenase Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors.
| Descriptor ID |
D043205
|
| MeSH Number(s) |
D08.811.682.047.436.174.300
|
| Concept/Terms |
11-beta-Hydroxysteroid Dehydrogenase Type 1- 11-beta-Hydroxysteroid Dehydrogenase Type 1
- 11beta-HSD1 Reductase
- 11beta HSD1 Reductase
- 11beta-HSD1
- 11beta-Hydroxysteroid Dehydrogenase Type 1
- 11beta Hydroxysteroid Dehydrogenase Type 1
- 11 beta-Hydroxysteroid Dehydrogenase Type 1
|
Below are MeSH descriptors whose meaning is more general than "11-beta-Hydroxysteroid Dehydrogenase Type 1".
Below are MeSH descriptors whose meaning is more specific than "11-beta-Hydroxysteroid Dehydrogenase Type 1".
This graph shows the total number of publications written about "11-beta-Hydroxysteroid Dehydrogenase Type 1" by people in UAMS Profiles by year, and whether "11-beta-Hydroxysteroid Dehydrogenase Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2017 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 | | 2015 | 2 | 0 | 2 | | 2014 | 4 | 0 | 4 | | 2013 | 4 | 0 | 4 | | 2012 | 3 | 0 | 3 | | 2011 | 1 | 1 | 2 | | 2010 | 2 | 1 | 3 | | 2009 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2007 | 4 | 1 | 5 | | 2006 | 4 | 0 | 4 | | 2005 | 1 | 1 | 2 | | 2004 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "11-beta-Hydroxysteroid Dehydrogenase Type 1" by people in Profiles over the past ten years.
-
Davidson CT, Miller E, Muir M, Dawson JC, Lee M, Aitken S, Serrels A, Webster SP, Homer NZM, Andrew R, Brunton VG, Hadoke PWF, Walker BR. 11?-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis. PLoS One. 2023; 18(3):e0255709.
-
Morgan RA, Keen JA, Homer N, Nixon M, McKinnon-Garvin AM, Moses-Williams JA, Davis SR, Hadoke PWF, Walker BR. Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction. Endocrinology. 2018 11 01; 159(11):3791-3800.
-
Webster SP, McBride A, Binnie M, Sooy K, Seckl JR, Andrew R, Pallin TD, Hunt HJ, Perrior TR, Ruffles VS, Ketelbey JW, Boyd A, Walker BR. Selection and early clinical evaluation of the brain-penetrant 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1) inhibitor UE2343 (Xanamem?). Br J Pharmacol. 2017 03; 174(5):396-408.
-
Anderson AJ, Andrew R, Homer NZ, Jones GC, Smith K, Livingstone DE, Walker BR, Stimson RH. Metformin Increases Cortisol Regeneration by 11?HSD1 in Obese Men With and Without Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2016 10; 101(10):3787-3793.
-
Coutinho AE, Kipari TM, Zhang Z, Esteves CL, Lucas CD, Gilmour JS, Webster SP, Walker BR, Hughes J, Savill JS, Seckl JR, Rossi AG, Chapman KE. 11?-Hydroxysteroid Dehydrogenase Type 1 Is Expressed in Neutrophils and Restrains an Inflammatory Response in Male Mice. Endocrinology. 2016 07; 157(7):2928-36.
-
White CI, Jansen MA, McGregor K, Mylonas KJ, Richardson RV, Thomson A, Moran CM, Seckl JR, Walker BR, Chapman KE, Gray GA. Cardiomyocyte and Vascular Smooth Muscle-Independent 11?-Hydroxysteroid Dehydrogenase 1 Amplifies Infarct Expansion, Hypertrophy, and the Development of Heart Failure After Myocardial Infarction in Male Mice. Endocrinology. 2016 Jan; 157(1):346-57.
-
Sooy K, Noble J, McBride A, Binnie M, Yau JL, Seckl JR, Walker BR, Webster SP. Cognitive and Disease-Modifying Effects of 11?-Hydroxysteroid Dehydrogenase Type 1 Inhibition in Male Tg2576 Mice, a Model of Alzheimer's Disease. Endocrinology. 2015 Dec; 156(12):4592-603.
-
Kilgour AH, Semple S, Marshall I, Andrews P, Andrew R, Walker BR. 11?-Hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men. J Clin Endocrinol Metab. 2015 Feb; 100(2):483-9.
-
Yau JL, Wheelan N, Noble J, Walker BR, Webster SP, Kenyon CJ, Ludwig M, Seckl JR. Intrahippocampal glucocorticoids generated by 11?-HSD1 affect memory in aged mice. Neurobiol Aging. 2015 Jan; 36(1):334-43.
-
Gambineri A, Fanelli F, Tomassoni F, Munarini A, Pagotto U, Andrew R, Walker BR, Pasquali R. Tissue-specific dysregulation of 11?-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls. Eur J Endocrinol. 2014 Jul; 171(1):47-57.
-
Chapagain A, Caton PW, Kieswich J, Andrikopoulos P, Nayuni N, Long JH, Harwood SM, Webster SP, Raftery MJ, Thiemermann C, Walker BR, Seckl JR, Corder R, Yaqoob MM. Elevated hepatic 11?-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia. Proc Natl Acad Sci U S A. 2014 Mar 11; 111(10):3817-22.
-
Kilgour AH, Gallagher IJ, MacLullich AM, Andrew R, Gray CD, Hyde P, Wackerhage H, Husi H, Ross JA, Starr JM, Chapman KE, Fearon KC, Walker BR, Greig CA. Increased skeletal muscle 11?HSD1 mRNA is associated with lower muscle strength in ageing. PLoS One. 2013; 8(12):e84057.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|